World News | Oxford, AstraZeneca to Resume Coronavirus Vaccine Trial
Get latest articles and stories on World at LatestLY. Oxford University says trials of a coronavirus vaccine that it is developing with pharmaceutical company AstraZeneca will resume, days after being paused due to a reported side-effect in a patient in the UK.
London, Sep 12 (AP) Oxford University says trials of a coronavirus vaccine that it is developing with pharmaceutical company AstraZeneca will resume, days after being paused due to a reported side-effect in a patient in the UK.
In a statement, the university said in large trials such as this “it is expected that some participants will become unwell and every case must be carefully evaluated to ensure careful assessment of safety.” It said that globally some 18,000 people have received the vaccine as part of the trial.
Also Read | Oxford-AstraZeneca’s COVID-19 Vaccine Trials in UK to Resume After Brief Pause Over Volunteer’s Illness.
It would not disclose information about the patient's illness for reasons of participant confidentiality but insisted that it is “committed to the safety of our participants and the highest standards of conduct in our studies and will continue to monitor safety closely.” Pauses in drug trials are commonplace. (AP)
(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)